CTOs on the Move

Impel NeuroPharma

www.impelneuropharma.com

 
Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Impel NeuroPharma raised $36M on 12/02/2016
Impel NeuroPharma raised $67.5M on 12/06/2018

Similar Companies

Healthline Med

Healthline Med is a Baldwin Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

iCRco

iCRco is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Bonutti Clinic

Bonutti Clinic is a Effingham, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Zimek Technologies

Zimek Technologies is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Noir Laser Co

Noir Laser Co LLC is a South Lyon, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.